| Micrornas in prostate cancer: an overview D Vanacore, M Boccellino, S Rossetti, C Cavaliere, C D'Aniello, ... Oncotarget 8 (30), 50240, 2017 | 140 | 2017 |
| Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences V Quagliariello, S Rossetti, C Cavaliere, R Di Palo, E Lamantia, ... Oncotarget 8 (18), 30606, 2017 | 66* | 2017 |
| Rectal/urinary toxicity after hypofractionated vs conventional radiotherapy in low/intermediate risk localized prostate cancer: systematic review and meta analysis R Di Franco, V Borzillo, V Ravo, G Ametrano, S Falivene, F Cammarota, ... Oncotarget 8 (10), 17383, 2017 | 37 | 2017 |
| Role of DNA repair machinery and p53 in the testicular germ cell cancer: a review FJ Romano, S Rossetti, V Conteduca, G Schepisi, C Cavaliere, ... Oncotarget 7 (51), 85641, 2016 | 34 | 2016 |
| Radiosurgery and stereotactic radiotherapy with cyberknife system for meningioma treatment R Di Franco, V Borzillo, V Ravo, S Falivene, FJ Romano, M Muto, ... The Neuroradiology Journal 31 (1), 18-26, 2018 | 32 | 2018 |
| Adjuvant treatment for locally advanced rectal cancer patients after preoperative chemoradiotherapy: when, and for whom? A De Stefano, R Moretto, L Bucci, S Pepe, FJ Romano, AC Cella, ... Clinical colorectal cancer 13 (3), 185-191, 2014 | 29 | 2014 |
| Rectal/urinary toxicity after hypofractionated vs. conventional radiotherapy in high risk prostate cancer: systematic review and meta analysis. R Di Franco, V Borzillo, V Ravo, G Ametrano, F Cammarota, S Rossetti, ... European Review for Medical & Pharmacological Sciences 21 (16), 2017 | 16 | 2017 |
| ATM and p53 combined analysis predicts survival in glioblastoma multiforme patients: A clinicopathologic study FJ Romano, E Guadagno, D Solari, G Borrelli, S Pignatiello, ... Journal of cellular biochemistry 119 (6), 4867-4877, 2018 | 13 | 2018 |
| Neutrophil-to-lymphocyte ratio is a major prognostic factor in non-small cell lung carcinoma patients undergoing first line immunotherapy with pembrolizumab FJ Romano, R Ronga, F Ambrosio, D Arundine, V Longo, D Galetta, ... Cancer Diagnosis & Prognosis 3 (1), 44, 2023 | 12 | 2023 |
| Impact of procedural pain in radiotherapy treatment R Di Franco, S Falivene, V Ravo, V Borzillo, FM Giugliano, A Argenone, ... WCRJ 4, e884-e890, 2017 | 4 | 2017 |
| ProEx C as diagnostic marker for detection of urothelial carcinoma in urinary samples: a review G Botti, MG Malzone, E La Mantia, M Montanari, D Vanacore, S Rossetti, ... International Journal of Medical Sciences 14 (6), 554, 2017 | 4 | 2017 |
| Salvage surgery after first-line alectinib for locally-advanced/metastatic ALK-rearranged NSCLC: pathological response and perioperative results F Lococo, A Cancellieri, M Chiappetta, A Leonetti, G Cardillo, F Zanelli, ... Clinical Lung Cancer 24 (5), 467-473, 2023 | 3 | 2023 |
| Hypofractionated versus conventional radiotherapy in patients with low/intermediate-risk localized prostate cancer: review of rectal and urinary toxicity R Di Franco, V Borzillo, V Ravo, G Ametrano, S Falivene, F Cammarota, ... WCRJ 3, e751, 2016 | 2 | 2016 |
| Bevacizumab maintenance in metastatic colorectal cancer: How long? A De Stefano, R Moretto, CA Cella, FJ Romano, L Raimondo, G Fiore, ... World Journal of Clinical Cases: WJCC 2 (11), 717, 2014 | 2 | 2014 |
| Sarcomatoid larynx carcinoma differential clinical evolution, on field statistical considerations F Ricciardiello, M Bocchetti, R Pellini, R Palladino, M Caraglia, ... American Journal of Otolaryngology 42 (3), 102934, 2021 | 1 | 2021 |
| Folinic acid in colorectal cancer: esquire or fellow knight? Real-world results from a mono institutional, retrospective study FJ Romano, C Barbato, M Biglietto, V Di Lauro, D Arundine, R Fiorentino, ... Oncotarget 12 (3), 221, 2021 | 1 | 2021 |
| Radiosurgery of brain metastases with CyberKnife® system: Role of image R Di Franco, V Borzillo, S Falivene, FM Giugliano, F Cammarota, ... WCRJ 4, e987, 2017 | 1 | 2017 |
| Prognostic relevance of Platelet-to-Lymphocyte Ratio in patients with Muscle-Invasive Bladder Cancer Patients: real world data from a retrospective multicenter analysis G Pecoraro, S Scagliarini, L Puglia, G Alberico, AR Amato, F Migliaccio, ... European Urology Open Science 57, S348, 2023 | | 2023 |
| EP05. 03-008 Surgery after First-Line Alectinib for (Locally) Advanced ALK-rearranged NSCLC: Pathological Response and Peri-Operative Results F Lococo, M Chiappetta, A Cancellieri, G Cardillo, F Zanelli, ... Journal of Thoracic Oncology 17 (9), S297-S298, 2022 | | 2022 |
| 13P High neutrophils-to-lymphocyte ratio (NLR) predicts poor survival of high-PD-L1-expressing metastatic non-small cell lung carcinoma patients undergoing first-line … FJ Romano, C Barbato, D Arundine, F Ambrosio, R Ronga, G Failla, ... Annals of Oncology 32, S1379, 2021 | | 2021 |
Rossella Di FrancoIstituto Nazionale Tumori Fondazione Pascale NapoliVerified email at virgilio.it
